Get the Stockscreener App
3.36
4.18%
0.17
Maravai Lifesciences Holdings Inc stock is traded at $3.36, with a volume of 304.49K.
It is up +4.18% in the last 24 hours and up +24.48% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$3.19
Open:
$3.25
24h Volume:
304.49K
Relative Volume:
0.21
Market Cap:
$487.56M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-3.7313
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
+6.52%
1M Performance:
+24.48%
6M Performance:
+81.61%
1Y Performance:
-58.51%
1-Day Range:
$3.24
$3.39
1-Week Range:
$3.12
$3.41
52-Week Range:
$1.665
$8.535
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
3.37 | 461.52M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.58 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.01 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
544.91 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
325.17 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
Will Maravai LifeSciences Holdings Inc. (MAR) stock beat growth indexesPortfolio Return Report & Free Accurate Trade Setup Notifications - newser.com
Is Maravai LifeSciences Holdings Inc. stock ready for a breakoutMarket Rally & Advanced Technical Signal Analysis - newser.com
Why Maravai LifeSciences Holdings Inc. (MAR) stock appeals to dividend investorsBull Run & Safe Capital Growth Stock Tips - newser.com
Research Frontiers And 2 Other Promising Penny Stocks To Watch - simplywall.st
Has Maravai LifeSciences Holdings Inc. formed a bullish divergenceM&A Rumor & AI Driven Price Forecasts - newser.com
Custom watchlist performance reports with Maravai LifeSciences Holdings Inc.Trend Reversal & Weekly High Conviction Ideas - newser.com
Detecting support and resistance levels for Maravai LifeSciences Holdings Inc.Portfolio Risk Report & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
What data driven models say about Maravai LifeSciences Holdings Inc.’s futureWeekly Investment Report & Technical Confirmation Alerts - newser.com
How high can Maravai LifeSciences Holdings Inc. stock goJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Maravai LifeSciences Holdings Inc. - newser.com
How to interpret RSI for Maravai LifeSciences Holdings Inc. stockGap Down & Weekly Setup with High ROI Potential - newser.com
How hedge fund analytics apply to Maravai LifeSciences Holdings Inc. stockTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN
Maravai LifeSciences (NASDAQ:MRVI) Trading 5.9% HigherShould You Buy? - MarketBeat
What’s next for Maravai LifeSciences Holdings Inc. stock priceGap Down & Low Drawdown Momentum Ideas - newser.com
Maravai LifeSciences Holdings Inc.’s volatility index tracking explainedJuly 2025 Final Week & Expert Approved Trade Ideas - newser.com
Tools to monitor Maravai LifeSciences Holdings Inc. recovery probabilityQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com
Is Maravai LifeSciences Holdings Inc. stock entering bullish territory2025 Trading Recap & Risk Controlled Stock Alerts - newser.com
How supply shortages influence Maravai LifeSciences Holdings Inc. (MAR) stockWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Using Python tools to backtest Maravai LifeSciences Holdings Inc. strategiesStock Surge & Verified Short-Term Plans - newser.com
Maravai postpones earnings release, delays annual report - MSN
Avantor, Inc. Appoints Gregory T. Lucier to Its Board of Directors - MarketScreener
Key resistance and support levels for Maravai LifeSciences Holdings Inc.2025 Risk Factors & Safe Capital Allocation Plans - newser.com
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, - GlobeNewswire
Voya Investment Management LLC Reduces Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - Defense World
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
What drives Maravai LifeSciences Holdings Inc stock priceGrowth vs. Value Investing & Build a Dividend-Powered Portfolio - earlytimes.in
Maravai LifeSciences acquires assets and intellectual property from Molecular Assemblies; shares rise - MSN
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):